13G Filing: Balyasny Asset Management and Sunesis Pharmaceuticals Inc (SNSS)

Page 16 of 30

Page 16 of 30 – SEC Filing


Item 1         (a) Name of Issuer:
Sunesis Pharmaceuticals, Inc. (the Company)
(b) Address of Issuers Principal Executive Offices:
395 Oyster Point Boulevard, Suite 400
South San Francisco, CA 94080
United States
Item 2 (a)  (c) This statement is filed on behalf of the following:

(1) Atlas Master Fund, Ltd. is a Cayman corporation (AMF), with its principal business
office at c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, George Town, Grand Cayman KY1-1104, Cayman Islands, British West Indies.

(2) Atlas Global, LLC is a Delaware limited liability company (AG), with its principal
business office at 181 West Madison, Suite 3600, Chicago, IL 60602. AG owns 20.43% of the equity interests in AMF.

(3) Atlas Global Investments, Ltd. is a Cayman corporation (AGI), with its principal
business office at c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, George Town, Grand Cayman KY1-1104, Cayman Islands, British West Indies. AGI owns 34.78% of the equity interests in AMF.

(4) Atlas Institutional Fund, LLC is a Delaware limited liability company (AIF LLC), with its
principal business office at 181 West Madison, Suite 3600, Chicago, IL 60602. AIF LLC owns 8.55% of the equity interests in AMF.

(5) Atlas Institutional Fund, Ltd. is a Cayman corporation (AIF LTD), with its principal
business office at c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, George Town, Grand Cayman KY1-1104, Cayman Islands, British West Indies. AIF LTD owns 23.83% of the equity interests in AMF.

(6) Atlas Global Japan Unit Trust is a Cayman exempted unit trust (AGJ), with its principal
business office at c/o CIBC Bank and Trust Company (Cayman) Limited, CIBC Financial Centre, 11 Dr. Roys Drive-3rd Floor, P.O. Box 694, Grand Cayman, Cayman Islands, British West
Indies. AGJ owns 11.97% of the equity interests in AMF.

(7) Atlas Enhanced Master Fund, Ltd. is a Cayman corporation (AEMF), with its principal
business office at c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, George Town, Grand Cayman KY1-1104, Cayman Islands, British West Indies.

Page 16 of 30 Pages

Follow Viracta Therapeutics Inc. (NASDAQ:VIRX)

Page 16 of 30